Beijing Luzhu Biotechnology Co., Ltd.

HKEX
2480
Stock
Yield per half year: -1.57%
Dividend yield: 0%
Sector: Healthcare

Reporting Beijing Luzhu Biotechnology Co., Ltd.

Reports

IFRS
Reporting Annual Quarterly
2023 2024
Финансовый отчет link link


Capitalization

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Капитализация, млрд HK$
6.47
Чистая прибыль, млрд HK$
-0.7252
EV, млрд HK$
5.85
EBITDA, млрд HK$
-0.175


Share

IFRS
Reporting Annual Quarterly
2023 2024 2025 LTM 5 year average CAGR 5
EPS -3.73
Цена акции ао 29.9 22.95 22 22 24.95 -9.72


Efficiency

IFRS
Reporting Annual
2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % -410.94 7.56
ROA, % -12.56 4.93
ROS, % 0 0 0 0 8.57
ROCE, % 0 0 0.37
Ebit margin, % 0 0
Рентаб EBITDA, % 0 0 -7.75
Чистая рентаб, % 0 8.57
Operation Margin, % 0 0 0 0 11.97


Coefficients

IFRS
Reporting Annual Quarterly
2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/BV
6.37 2.95
P/FCF
0 0 0 0 34.85
E/P
-0.1121 -0.1121 -0.1121 -0.1121 0.03 -0.1121 0.00
EV/EBIT
0 0 0
EV/EBITDA
-8.19 -5.04
EV/S
0 0 0 0 32.69
EV/FCF
0 0 0 24.34
Debt/EBITDA
0 0 0 0 0.66
Netdebt/Ebitda
0 0 0 0 -0.66
Debt/Ratio
0 0 0 0 0.10
Debt/Equity
0 0 0 0 0.55
Debt/Net Income
0 0 0 0 0.85
PEG
0 0
Бета
3.15 0.2402 -0.3099 -0.3099 1.41 1.03 -146.16
Индекс Альтмана
0 0 0 0 5.08


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 2.92
Дивиденды / прибыль, %
0 22.32


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 2024 CAGR 5
Персонал, чел
129 133 1.54